Novan Receives Phase 2 NIH Federal Grant of Approximately $1.0 Million
20 févr. 2020 08h15 HE
|
Novan, Inc.
Provides funds to evaluate the mechanistic antiviral activity of WH602Novan to progress IND-enabling toxicology and pharmacology studies for WH602 Grant is additive to $223,000 Phase 1 NIH grant...
Novan Awarded Approximately $1.1 Million Grant by Department of Defense
20 sept. 2019 08h30 HE
|
Novan, Inc.
Funds to progress women’s health product candidate, WH504Additive to recently announced NIH grant for WH602Women’s health initiative to focus on potential HPV related onco-virus therapeutics ...
Novan Advances Women’s Health Business Unit with Non-Dilutive Funding
14 août 2019 08h15 HE
|
Novan, Inc.
Company has received NIH federal grant of approximately $223,000Anticipates additional federal grant of approximately $1.0 millionWomen’s health initiative to focus on potential HPV related onco-virus...
Novan Creates Dedicated Women’s Health Business Unit
25 oct. 2018 07h05 HE
|
Novan, Inc.
Business unit will focus on Novan’s proprietary nitric oxide technology and its application to target high-risk human papillomavirus (HPV) and associated cancers affecting women such as cervical...